Ian Mortimer insider trades: Xenon Pharmaceuticals (XENE) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ian reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | XENE | ↑ Buy | 30,000 | $37.38 | $1.1M | Direct | Oct 1, 2026 (1d) |
| Mar 10, 2026 | XENE | ↓ Sell | 281,269 | $60.32 | $17.0M | Direct | Mar 11, 2026 (1d) |
| Jan 2, 2026 | XENE | ↓ Sell | 40,000 | $44.43 | $1.8M | Direct | Jan 2, 2026 (0d) |
| Dec 8, 2025 | XENE | ↓ Sell | 25,205 | $45.33 | $1.1M | Direct | Dec 9, 2025 (1d) |
| Nov 28, 2025 | XENE | ↓ Sell | 97 | $45.01 | $4K | Direct | Dec 3, 2025 (5d) |
| Oct 1, 2025 | XENE | ↓ Sell | 25,000 | $40.16 | $1.0M | Direct | Oct 1, 2025 (0d) |
| Jan 27, 2025 | XENE | ↓ Sell | 55,000 | $40.25 | $2.2M | Direct | Jan 27, 2025 (0d) |
| May 24, 2023 | XENE | ↓ Sell | 31,655 | $41.41 | $1.3M | Direct | May 26, 2023 (2d) |
| Aug 10, 2017 | XENE | ↑ Buy | 10,000 | $2.90 | $29K | By Spouse | Aug 14, 2017 (4d) |
| Aug 10, 2017 | XENE | ↑ Buy | 5,000 | $2.85 | $14K | Direct | Aug 14, 2017 (4d) |
| Jun 24, 2016 | XENE | ↑ Buy | 4,300 | $6.23 | $27K | By spouse | Jun 28, 2016 (4d) |
| Jun 24, 2016 | XENE | ↑ Buy | 1,000 | $6.15 | $6K | Direct | Jun 28, 2016 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other XENE insiders
Open-market trades in the last 12 months
About Ian Mortimer's insider trades
Ian Mortimer is President & CEO at Xenon Pharmaceuticals (XENE). Since Jun 24, 2016, Ian has reported 5 open-market purchases worth $1.2M and 7 sales worth $24.4M on SEC Form 4. In the last 12 months: 1 buy ($1.1M) and 4 sales ($19.9M).
Their filings also include grants and awards (15 filings), option exercises (5 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every XENE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.